Remote Control of Blood Sugar: Electromagnetic Fields treat Diabetes in Animal Models

Study suggests EMFs alter redox signaling to improve insulin sensitivity. Researchers from the University of Iowa may have discovered a safe new way to manage blood sugar non-invasively. Exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day normalizes two major hallmarks of type 2 diabetes, according to new findings published Oct. 6 in Cell Metabolism.

“We’ve built a remote control to manage diabetes,” says Calvin Carter, PhD, one of the study’s lead authors and a postdoc in the lab of senior author Val Sheffield, MD, PhD, professor of pediatrics, and of ophthalmology and visual sciences at the UI Carver College of Medicine...

Read More

Spinach: Good for Popeye and the Planet

Schematic of the Procedure for Preparing Spinach-Derived Carbon Nanosheets ACS Omega 2020, 5, 38, 24367-24378

Chemistry experiments show potential to power fuel cells. Spinach, when converted from its leafy, edible form into carbon nanosheets, acts as a catalyst for an oxygen reduction reaction in fuel cells and metal-air batteries.

An oxygen reduction reaction is one of two reactions in fuel cells and metal-air batteries and is usually the slower one that limits the energy output of these devices. Researchers have long known that certain carbon materials can catalyze the reaction. But those carbon-based catalysts don’t always perform as good or better than the traditional platinum-based catalysts...

Read More

Trans-Neptunian Object Arrokoth: Flattening of a Snowman

Arrokoth’s flattened shape can only be seen from a certain perspective. The first images returned by NASA’s New… [more]
© NASA/Johns Hopkins University Applied Physics Laboratory/Southwest Research Institute

Only in the course of several million years did Arrokoth, also known by its nickname Ultima Thule, acquire its bizarre, pancake-flat shape. The trans-Neptunian object Arrokoth, also known as Ultima Thule, which NASA’s space probe New Horizons passed on New Year’s Day 2019, may have changed its shape significantly in the first 100 million years since its formation...

Read More

Preliminary results of 2 large Immune Therapy studies show promise in Advanced Cervical Cancer

Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell death protein 1)-based immune therapy for metastatic cervical cancer suggest potential new treatment options for a disease that currently has limited effective options and disproportionately impacts younger women.

David O’Malley, MD, of The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), presented the preliminary study results at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 on Sept. 18. O’Malley was the lead presenter for both trials, which were sponsored by Agenus Inc.

Each study involved more than 150 patients with recurrent or metastatic cervical can...

Read More